A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury

Neurocritical Care

Volumn 14, Issue 1, 2011, Pages 97-102

  Dhar, Rajat ^b   Murphy Human, Theresa ^a  

^a BARNES JEWISH HOSPITAL   (United States)

^b NONE

Author keywords

Hyponatremia; Intracranial pressure; Traumatic brain injury; Vasopressin

Indexed keywords

CONIVAPTAN; SODIUM;

ADULT; ARTICLE; BOLUS INJECTION; BRAIN EDEMA; BRAIN INFARCTION; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; EPIDURAL HEMATOMA; FEMALE; GLASGOW COMA SCALE; HUMAN; HYPONATREMIA; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; PRIORITY JOURNAL; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; SUBDURAL HEMATOMA; TRAUMATIC BRAIN INJURY;

BENZAZEPINES; BRAIN INJURIES; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; HYPONATREMIA; INTRACRANIAL HYPERTENSION; RECEPTORS, VASOPRESSIN; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79551550397     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-010-9366-x     Document Type: Article

References (33)

1. N Moro Y Katayama T Igarashi T Mori T Kawamata J Kojima 2007 Hyponatremia in patients with traumatic brain injury: incidence, mechanism, and response to sodium supplementation or retention therapy with hydrocortisone Surg Neurol 68 4 387 393 10.1016/j.surneu.2006.11.052 17905062 (Pubitemid 47464463)
2. M Sherlock E O'Sullivan A Agha, et al. 2009 Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients Postgrad Med J 85 1002 171 175 1:CAS:528:DC%2BD1MXmvVOgsrg%3D 10.1136/pgmj.2008.072819 19417163
3. JD Born P Hans S Smitz JJ Legros S Kay 1985 Syndrome of inappropriate secretion of antidiuretic hormone after severe head injury Surg Neurol 23 4 383 387 1:STN:280:DyaL2M7kt1Oksw%3D%3D 10.1016/0090-3019(85)90212-5 3975827 (Pubitemid 15114419)
4. S Brimioulle C Orellana-Jimenez A Aminian JL Vincent 2008 Hyponatremia in neurological patients: cerebral salt wasting versus inappropriate antidiuretic hormone secretion Intensive Care Med 34 1 125 131 1:CAS:528:DC%2BD1cXosl2lurs%3D 10.1007/s00134-007-0905-7 17952405
5. SR Gullans JG Verbalis 1993 Control of brain volume during hyperosmolar and hypoosmolar conditions Annu Rev Med 44 289 301 1:STN:280: DyaK3s3js1elsQ%3D%3D 10.1146/annurev.me.44.020193.001445 8476251
6. RH Sterns SM Silver 2006 Brain volume regulation in response to hypo-osmolality and its correction Am J Med 119 (7 Suppl 1) S12 S16 1:CAS:528:DC%2BD28XnslWjtb4%3D 10.1016/j.amjmed.2006.05.003 16843080
7. MM Treggiari N Schutz ND Yanez JA Romand 2007 Role of intracranial pressure values and patterns in predicting outcome in traumatic brain injury: a systematic review Neurocrit Care 6 2 104 112 10.1007/s12028-007-0012-1 17522793 (Pubitemid 46934020)
8. J Carpenter S Weinstein J Myseros G Vezina MJ Bell 2007 Inadvertent hyponatremia leading to acute cerebral edema and early evidence of herniation Neurocrit Care 6 3 195 199 10.1007/s12028-007-0032-x 17572863 (Pubitemid 350239287)
9. Wakai A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev. 2007;(1):CD001049.
10. G Francony B Fauvage D Falcon, et al. 2008 Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure Crit Care Med 36 3 795 800 1:CAS:528:DC%2BD1cXjtlyhs7Y%3D 10.1097/CCM. 0B013E3181643B41 18209674
11. AJ Kerwin MA Schinco JJ Tepas III WH Renfro EA Vitarbo M Muehlberger 2009 The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study J Trauma 67 2 277 282 1:CAS:528:DC%2BD1MXpsFyhtb4%3D 10.1097/TA.0b013e3181acc726 19667879
12. RP Paczynski YY He MN Diringer CY Hsu 1997 Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction Stroke 28 7 1437 1443 1:CAS:528:DyaK2sXltFCitbo%3D 9227697
13. EM Manno RE Adams CP Derdeyn WJ Powers MN Diringer 1999 The effects of mannitol on cerebral edema after large hemispheric cerebral infarct Neurology 52 3 583 587 1:CAS:528:DyaK1MXhtlShsrs%3D 10025792
14. TO Videen AR Zazulia EM Manno, et al. 2001 Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke Neurology 57 11 2120 2122 1:STN:280:DC%2BD3MjgtFCrsQ%3D%3D 11739839
15. SG Keyrouz R Dhar MN Diringer 2008 Variation in osmotic response to sustained mannitol administration Neurocrit Care 9 2 204 209 1:CAS:528:DC%2BD1cXhtlGisbrL 10.1007/s12028-008-9118-3 18563637
16. G Decaux A Soupart G Vassart 2008 Non-peptide arginine-vasopressin antagonists: the vaptans Lancet 371 9624 1624 1632 1:CAS:528: DC%2BD1cXlslWhsbc%3D 10.1016/S0140-6736(08)60695-9 18468546 (Pubitemid 351626846)
17. T Murphy R Dhar M Diringer 2009 Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit Neurocrit Care 11 1 14 19 1:CAS:528:DC%2BD1MXotFyms7k%3D 10.1007/s12028-008-9179-3 19123060
18. WL Wright WH Asbury JL Gilmore OB Samuels 2009 Conivaptan for hyponatremia in the neurocritical care unit Neurocrit Care 11 1 6 13 1:CAS:528:DC%2BD1MXotFyms7Y%3D 10.1007/s12028-008-9152-1 19003543
19. Vaprisol (conivaptan hydrochloride injection). Prescribing information. 2007. Deerfield, IL: Astellas Pharma US, Inc.
20. LL Larive DH Rhoney D Parker Jr WM Coplin JR Carhuapoma 2004 Introducing hypertonic saline for cerebral edema: an academic center experience Neurocrit Care 1 4 435 440 10.1385/NCC:1:4:435 16174946 (Pubitemid 41278331)
21. MA Koenig M Bryan JL Lewin III MA Mirski RG Geocadin RD Stevens 2008 Reversal of transtentorial herniation with hypertonic saline Neurology 70 13 1023 1029 1:CAS:528:DC%2BD1cXjtlKjurY%3D 10.1212/01.wnl.0000304042.05557.60 18272864 (Pubitemid 351451321)
22. GA Rosenberg E Estrada WT Kyner 1990 Vasopressin-induced brain edema is mediated by the V1 receptor Adv Neurol 52 149 154 1:STN:280:DyaK3cznt1WmtQ%3D%3D 2144395
23. ME Raichle RL Grubb Jr 1978 Regulation of brain water permeability by centrally-released vasopressin Brain Res 143 1 191 194 1:CAS:528: DyaE1cXhvVemu7g%3D 10.1016/0006-8993(78)90766-7 415801 (Pubitemid 8274416)
24. H Niermann M Amiry-Moghaddam K Holthoff OW Witte OP Ottersen 2001 A novel role of vasopressin in the brain: modulation of activity-dependent water flux in the neocortex J Neurosci 21 9 3045 3051 1:CAS:528:DC%2BD3MXjtFyqur4%3D 11312289
25. A Vakili H Kataoka N Plesnila 2005 Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia J Cereb Blood Flow Metab 25 8 1012 1019 1:CAS:528:DC%2BD2MXpsFGlurk%3D 10.1038/sj.jcbfm.9600097 15744246 (Pubitemid 41061716)
26. A Kleindienst G Fazzina JG Dunbar R Glisson A Marmarou 2006 Protective effect of the V1a receptor antagonist SR49059 on brain edema formation following middle cerebral artery occlusion in the rat Acta Neurochir Suppl 96 303 306 1:STN:280:DC%2BD283kslKqsg%3D%3D 10.1007/3-211-30714-1-65 16671476
27. R Trabold S Krieg K Scholler N Plesnila 2008 Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice J Neurotrauma 25 12 1459 1465 10.1089/neu.2008.0597 19118456
28. K Taya S Gulsen K Okuno R Prieto CR Marmarou A Marmarou 2008 Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema Acta Neurochir Suppl 102 425 429 10.1007/978-3-211- 85578-2-83 19388360
29. A Shuaib WC Xu T Yang R Noor 2002 Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model Stroke 33 12 3033 3037 1:CAS:528:DC%2BD38XptVSht7g%3D 10.1161/01.STR.0000039405.31526.06 12468809 (Pubitemid 35462884)
30. X Liu S Nakayama M Amiry-Moghaddam OP Ottersen A Bhardwaj 2010 Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke Neurocrit Care 12 1 124 131 1:CAS:528:DC%2BC3cXhslCisrw%3D 10.1007/s12028-009- 9277-x 19806476
31. N Fernandez MA Martinez AL Garcia-Villalon L Monge G Dieguez 2001 Cerebral vasoconstriction produced by vasopressin in conscious goats: role of vasopressin V(1) and V(2) receptors and nitric oxide Br J Pharmacol 132 8 1837 1844 1:CAS:528:DC%2BD3MXjt1artrk%3D 10.1038/sj.bjp.0704034 11309256
32. AH Molnar C Varga A Berko, et al. 2008 Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260 Prog Brain Res 170 519 525 1:CAS:528:DC%2BD1cXht1Cjt77M 10.1016/S0079-6123(08)00439-1 18655905 (Pubitemid 352024379)
33. BR Nathan 2007 Cerebral correlates of hyponatremia Neurocrit Care 6 1 72 78 1:CAS:528:DC%2BD2sXnsVSktrg%3D 10.1385/NCC:6:1:72 17356196 (Pubitemid 46424456)